
    
      Serum NGAL is currently being used as a test to determine the likelihood of developing renal
      failure. However, in a previous study, serum NGAL correlated with neurological prognosis in
      post cardiac arrest syndrome patients. This prospective study attempts to see the role of
      serum NGAL as a prognostic factor by including a sufficient number of patients.
    
  